Preventing secondary cancer
It’s early days, but Tel Aviv University scientists have managed in lab tests to reduce the incidence of breast cancer relapse by 88%. They used two chemotherapies – doxorubicin and cisplatin together, which reduced the spread of cancer cells (metastasis) that occurred using just one therapy.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink